Literature DB >> 17317969

Genetic predisposition to familial neuroblastoma: identification of two novel genomic regions at 2p and 12p.

Luca Longo1, Emanuele Panza, Francesca Schena, Marco Seri, Marcella Devoto, Giovanni Romeo, Carla Bini, Giuseppe Pappalardo, Gian Paolo Tonini, Patrizia Perri.   

Abstract

OBJECTIVES: The rarity of familial neuroblastoma (NB) has allowed only a few linkage studies, most of which did not show any evidence of linkage to regions involved in somatic alterations or to genes implicated in other neurocristopathies seldom associated with NB. We screened a highly informative family with recurrent NB by genome-wide linkage analysis aimed at identifying chromosomal regions for NB predisposing genes.
METHODS: A genome-wide screen was performed using 382 microsatellite markers. Multipoint model-based linkage analysis was carried out under a dominant mode of inheritance for the disease using the 'affected only' approach.
RESULTS: Our analysis identified two haplotypes co-segregating with the disease on chromosomes 2p and 12p, and yielded maximum lod-score values of 3.01 (p < 0.0001) for markers on both intervals.
CONCLUSIONS: Evidence of linkage was reported at 16p in North American families, whereas our studies excluded this interval and indicated other loci for disease predisposition, thus confirming the remarkable genetic heterogeneity of NB. These results suggest an oligogenic inheritance in NB involving more loci in genetic determination of the disease.

Entities:  

Mesh:

Year:  2007        PMID: 17317969     DOI: 10.1159/000099997

Source DB:  PubMed          Journal:  Hum Hered        ISSN: 0001-5652            Impact factor:   0.444


  11 in total

1.  Genome-wide linkage analysis to identify genetic modifiers of ALK mutation penetrance in familial neuroblastoma.

Authors:  Marcella Devoto; Claudia Specchia; Marci Laudenslager; Luca Longo; Hakon Hakonarson; John Maris; Yael Mossé
Journal:  Hum Hered       Date:  2011-07-06       Impact factor: 0.444

2.  Absence of MGST1 mRNA and protein expression in human neuroblastoma cell lines and primary tissue.

Authors:  Michael J Kelner; Mitchell B Diccianni; Alice L Yu; Mary R Rutherford; Leita A Estes; Ralf Morgenstern
Journal:  Free Radic Biol Med       Date:  2014-01-29       Impact factor: 7.376

3.  PHOX2B-mediated regulation of ALK expression: in vitro identification of a functional relationship between two genes involved in neuroblastoma.

Authors:  Tiziana Bachetti; Daniela Di Paolo; Simona Di Lascio; Valentina Mirisola; Chiara Brignole; Marta Bellotti; Irene Caffa; Chiara Ferraris; Michele Fiore; Diego Fornasari; Roberto Chiarle; Silvia Borghini; Ulrich Pfeffer; Mirco Ponzoni; Isabella Ceccherini; Patrizia Perri
Journal:  PLoS One       Date:  2010-10-01       Impact factor: 3.240

4.  Chromosome 6p22 locus associated with clinically aggressive neuroblastoma.

Authors:  John M Maris; Yael P Mosse; Jonathan P Bradfield; Cuiping Hou; Stefano Monni; Richard H Scott; Shahab Asgharzadeh; Edward F Attiyeh; Sharon J Diskin; Marci Laudenslager; Cynthia Winter; Kristina A Cole; Joseph T Glessner; Cecilia Kim; Edward C Frackelton; Tracy Casalunovo; Andrew W Eckert; Mario Capasso; Eric F Rappaport; Carmel McConville; Wendy B London; Robert C Seeger; Nazneen Rahman; Marcella Devoto; Struan F A Grant; Hongzhe Li; Hakon Hakonarson
Journal:  N Engl J Med       Date:  2008-05-07       Impact factor: 91.245

5.  Identification of ALK as a major familial neuroblastoma predisposition gene.

Authors:  Yaël P Mossé; Marci Laudenslager; Luca Longo; Kristina A Cole; Andrew Wood; Edward F Attiyeh; Michael J Laquaglia; Rachel Sennett; Jill E Lynch; Patrizia Perri; Geneviève Laureys; Frank Speleman; Cecilia Kim; Cuiping Hou; Hakon Hakonarson; Ali Torkamani; Nicholas J Schork; Garrett M Brodeur; Gian P Tonini; Eric Rappaport; Marcella Devoto; John M Maris
Journal:  Nature       Date:  2008-08-24       Impact factor: 49.962

Review 6.  Retinoblastoma and Neuroblastoma Predisposition and Surveillance.

Authors:  Junne Kamihara; Franck Bourdeaut; William D Foulkes; Jan J Molenaar; Yaël P Mossé; Akira Nakagawara; Andreu Parareda; Sarah R Scollon; Kami Wolfe Schneider; Alison H Skalet; Lisa J States; Michael F Walsh; Lisa R Diller; Garrett M Brodeur
Journal:  Clin Cancer Res       Date:  2017-07-01       Impact factor: 12.531

7.  Selective therapeutic targeting of the anaplastic lymphoma kinase with liposomal siRNA induces apoptosis and inhibits angiogenesis in neuroblastoma.

Authors:  Daniela Di Paolo; Chiara Ambrogio; Fabio Pastorino; Chiara Brignole; Cinzia Martinengo; Roberta Carosio; Monica Loi; Gabriella Pagnan; Laura Emionite; Michele Cilli; Domenico Ribatti; Theresa M Allen; Roberto Chiarle; Mirco Ponzoni; Patrizia Perri
Journal:  Mol Ther       Date:  2011-08-09       Impact factor: 11.454

8.  Neuroblastoma-targeted nanoparticles entrapping siRNA specifically knockdown ALK.

Authors:  Daniela Di Paolo; Chiara Brignole; Fabio Pastorino; Roberta Carosio; Alessia Zorzoli; Marzia Rossi; Monica Loi; Gabriella Pagnan; Laura Emionite; Michele Cilli; Silvia Bruno; Roberto Chiarle; Theresa M Allen; Mirco Ponzoni; Patrizia Perri
Journal:  Mol Ther       Date:  2011-04-12       Impact factor: 11.454

9.  The emerging molecular pathogenesis of neuroblastoma: implications for improved risk assessment and targeted therapy.

Authors:  Nadine Van Roy; Katleen De Preter; Jasmien Hoebeeck; Tom Van Maerken; Filip Pattyn; Pieter Mestdagh; Joëlle Vermeulen; Jo Vandesompele; Frank Speleman
Journal:  Genome Med       Date:  2009-07-27       Impact factor: 11.117

10.  Identification of GALNT14 as a novel neuroblastoma predisposition gene.

Authors:  Marilena De Mariano; Roberta Gallesio; Marco Chierici; Cesare Furlanello; Massimo Conte; Alberto Garaventa; Michela Croce; Silvano Ferrini; Gian Paolo Tonini; Luca Longo
Journal:  Oncotarget       Date:  2015-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.